Roivant Sciences

About:

Roivant Sciences is a biopharmaceutical company focused on the development of medicines and healthcare technologies to patients.

Website: http://www.roivant.com

Twitter/X: roivant

Top Investors: Palantir Technologies, Fidelity, Founders Fund, RTW Investments, Patient Square Capital

Description:

Roivant Sciences is a biopharmaceutical company focused on completing the development of promising late-stage drug candidates. Roivant’s mission is to reduce the time and cost of developing new medicines for patients and to share those savings with the healthcare system. Roivant does this by building Vants - nimble, entrepreneurial biotech and healthcare technology companies with a unique approach to sourcing talent, aligning incentives, and deploying the technology. In addition to its biopharmaceutical subsidiaries, Roivant also builds technology-focused Vants focused on improving the process of developing and commercializing medicines.

Total Funding Amount:

$2.47B

Estimated Revenue Range:

$50M to $100M

Headquarters Location:

New York, New York, United States

Founded Date:

2014-05-01

Contact Email:

info(AT)roivant.com

Hub Tags:

Exited Unicorn

Founders:

Vivek Ramaswamy

Number of Employees:

501-1000

Last Funding Date:

2023-02-02

IPO Status:

Public

© 2025 bioDAO.ai